Advances in balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.

Pulmonary Circulation
Ehtisham MahmudDavid Poch

Abstract

Balloon pulmonary angioplasty (BPA) is an emerging treatment option for patients with chronic thromboembolic pulmonary hypertension (CTEPH) who have inoperable, segmental/subsegmental disease, or residual disease after pulmonary endarterectomy. In the past decade, advances in the techniques for BPA have led to better clinical outcomes with improvements in hemodynamics, pulmonary perfusion, exercise tolerance, functional capacity, and quality of life. We present the experience with BPA at our university, the largest CTEPH center in the world, followed by reviewing the published data regarding the efficacy and safety of BPA in patients with CTEPH. There is increasing evidence to support that the initial hemodynamic improvement is sustained for ≥3 years after the procedure. Although infrequent, complications observed with BPA are associated with pulmonary vascular injury or rarely reperfusion pulmonary edema. As the technique for percutaneous pulmonary artery revascularization has improved, the procedural risk and complications have continued to decrease. This promising technique continues to develop, and future research is required to demonstrate the long-term benefits of BPA, standardize the technique, and define a uniform insti...Continue Reading

References

Dec 22, 2011·Circulation Journal : Official Journal of the Japanese Circulation Society·Koichiro SugimuraHiroaki Shimokawa
Nov 30, 2012·Circulation. Cardiovascular Interventions·Hiroki MizoguchiHiromi Matsubara
Feb 7, 2013·Circulation Journal : Official Journal of the Japanese Circulation Society·Shunsuke TatebeHiroaki Shimokawa
Aug 21, 2014·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Yu TaniguchiNoriaki Emoto
Feb 6, 2017·Circulation Journal : Official Journal of the Japanese Circulation Society·Szymon DarochaMarcin Kurzyna
Mar 31, 2017·European Respiratory Review : an Official Journal of the European Respiratory Society·Joanna Pepke-ZabaMarius M Hoeper
Mar 31, 2017·European Respiratory Review : an Official Journal of the European Respiratory Society·Irene LangPhilippe Brenot
Nov 5, 2017·Circulation. Cardiovascular Quality and Outcomes·Aiko OgawaHiromi Matsubara
Nov 22, 2017·Interventional Cardiology Clinics·Ehtisham MahmudNick H Kim
Dec 29, 2017·Pulmonary Circulation·Christoph B WiedenrothChristoph Liebetrau
May 26, 2018·Journal of the American College of Cardiology·Ehtisham MahmudWilliam R Auger
Nov 10, 2018·The European Respiratory Journal·Emilia Maria SwietlikMark R Toshner
Dec 14, 2018·The European Respiratory Journal·Nick H KimDavid P Jenkins
Feb 19, 2019·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Nobutaka IkedaMasato Nakamura
Mar 10, 2019·International Journal of Cardiology·Muhammad Shahzeb KhanRichard A Krasuski
Apr 27, 2019·The European Respiratory Journal·Philippe BrenotGérald Simonneau
May 20, 2019·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Yu TaniguchiGérald Simonneau
Oct 28, 2019·The European Respiratory Journal·Xavier JaïsGérald Simonneau

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.